Perrigo (PRGO) Change in Cash (2013 - 2026)
Perrigo (PRGO) posted quarterly Change in Cash of -$174.4 million for Q1 2026, down 23.08% year-over-year from -$226.7 million in Q1 2025, and down 275.28% quarter-over-quarter from $99.5 million in Q4 2025.
Perrigo (PRGO) Change in Cash (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Change in Cash for 14 consecutive years, with -$174.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 23.08% year-over-year to -$174.4 million; the TTM figure through Mar 2026 stood at -$57.6 million (up 76.14% YoY), while the FY2025 annual figure was -$24.9 million, up 87.06% from the prior year.
- Change in Cash fell to -$174.4 million in Q1 2026 per PRGO's latest filing, from $99.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $920.7 million in Q3 2024 and bottomed at -$1.5 billion in Q3 2022.
- Historically, Change in Cash has averaged -$89.4 million across 5 years, with a median of -$16.6 million in 2022.
- On a YoY basis, Change in Cash climbed as much as 2036.19% in 2024 and fell as far as 5359.09% in 2024.
- Perrigo's Change in Cash stood at $132.0 million in 2022, then grew by 15.91% to $153.0 million in 2023, then sank by 691.31% to -$904.7 million in 2024, then surged by 111.0% to $99.5 million in 2025, then sank by 275.28% to -$174.4 million in 2026.
- Business Quant data shows PRGO's Change in Cash at -$174.4 million in Q1 2026, $99.5 million in Q4 2025, and -$19.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 40.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 40.20 Mn |
| Mar 28, 2026 | -174.40 Mn |
| Dec 31, 2025 | 99.50 Mn |
| Sep 27, 2025 | -19.80 Mn |
| Jun 28, 2025 | 37.10 Mn |
| Mar 29, 2025 | -141.70 Mn |
| Dec 31, 2024 | -904.70 Mn |
| Sep 28, 2024 | 920.70 Mn |
| Jun 29, 2024 | -115.70 Mn |
| Mar 30, 2024 | -92.80 Mn |
| Dec 31, 2023 | 153.00 Mn |
| Sep 30, 2023 | 43.10 Mn |
| Jul 1, 2023 | 2.20 Mn |
| Apr 1, 2023 | -47.70 Mn |
| Dec 31, 2022 | 132.00 Mn |
| Oct 1, 2022 | -16.60 Mn |
| Jul 2, 2022 | -1.48 Bn |
| Apr 2, 2022 | 86.20 Mn |
| Dec 31, 2021 | -208.90 Mn |
| Oct 2, 2021 | 1.75 Bn |